Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line.
Saved in:
| Title: | Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line. |
|---|---|
| Authors: | Dolskiy AA; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia., Bodnev SA; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia., Nazarenko AA; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia., Smirnova AM; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia., Pyankova OG; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia., Matveeva AK; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia., Grishchenko IV; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia., Tregubchak TV; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia., Pyankov OV; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia., Ryzhikov AB; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia., Gavrilova EV; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia., Maksyutov RA; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia., Yudkin DV; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia. |
| Source: | Frontiers in molecular biosciences [Front Mol Biosci] 2020 Dec 18; Vol. 7, pp. 616798. Date of Electronic Publication: 2020 Dec 18 (Print Publication: 2020). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653173 Publication Model: eCollection Cited Medium: Print ISSN: 2296-889X (Print) Linking ISSN: 2296889X NLM ISO Abbreviation: Front Mol Biosci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33537341 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dolskiy+AA%22">Dolskiy AA</searchLink>; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia.<br /><searchLink fieldCode="AU" term="%22Bodnev+SA%22">Bodnev SA</searchLink>; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia.<br /><searchLink fieldCode="AU" term="%22Nazarenko+AA%22">Nazarenko AA</searchLink>; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia.<br /><searchLink fieldCode="AU" term="%22Smirnova+AM%22">Smirnova AM</searchLink>; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia.<br /><searchLink fieldCode="AU" term="%22Pyankova+OG%22">Pyankova OG</searchLink>; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia.<br /><searchLink fieldCode="AU" term="%22Matveeva+AK%22">Matveeva AK</searchLink>; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia.<br /><searchLink fieldCode="AU" term="%22Grishchenko+IV%22">Grishchenko IV</searchLink>; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia.<br /><searchLink fieldCode="AU" term="%22Tregubchak+TV%22">Tregubchak TV</searchLink>; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia.<br /><searchLink fieldCode="AU" term="%22Pyankov+OV%22">Pyankov OV</searchLink>; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia.<br /><searchLink fieldCode="AU" term="%22Ryzhikov+AB%22">Ryzhikov AB</searchLink>; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia.<br /><searchLink fieldCode="AU" term="%22Gavrilova+EV%22">Gavrilova EV</searchLink>; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia.<br /><searchLink fieldCode="AU" term="%22Maksyutov+RA%22">Maksyutov RA</searchLink>; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia.<br /><searchLink fieldCode="AU" term="%22Yudkin+DV%22">Yudkin DV</searchLink>; State Research Center of Virology and Biotechnology 'Vector', Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, Novosibirsk, Russia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101653173%22">Frontiers in molecular biosciences</searchLink> [Front Mol Biosci] 2020 Dec 18; Vol. 7, pp. 616798. <i>Date of Electronic Publication: </i>2020 Dec 18 (<i>Print Publication: </i>2020). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101653173 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2296-889X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222296889X%22">2296889X </searchLink><i>NLM ISO Abbreviation: </i>Front Mol Biosci <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33537341 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fmolb.2020.616798 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 616798 Titles: – TitleFull: Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dolskiy AA – PersonEntity: Name: NameFull: Bodnev SA – PersonEntity: Name: NameFull: Nazarenko AA – PersonEntity: Name: NameFull: Smirnova AM – PersonEntity: Name: NameFull: Pyankova OG – PersonEntity: Name: NameFull: Matveeva AK – PersonEntity: Name: NameFull: Grishchenko IV – PersonEntity: Name: NameFull: Tregubchak TV – PersonEntity: Name: NameFull: Pyankov OV – PersonEntity: Name: NameFull: Ryzhikov AB – PersonEntity: Name: NameFull: Gavrilova EV – PersonEntity: Name: NameFull: Maksyutov RA – PersonEntity: Name: NameFull: Yudkin DV IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 12 Text: 2020 Dec 18 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 2296-889X Numbering: – Type: volume Value: 7 Titles: – TitleFull: Frontiers in molecular biosciences Type: main |
| ResultId | 1 |
